Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002329

Chief Accounting Officer acquired 2,287 shares (grant or award)

  • Chief Accounting Officer gave up 269 shares (to pay taxes)
  • Chief Accounting Officer acquired 775 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Megna Michael R · Chief Accounting Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-30 Grant or award : show line 1 in the form +641 $9.51 $6,096 1,778 D
2020-12-31 Grant or award : show line 2 in the form +405 $15.02 $6,083 2,183 D
2021-07-15 Grant or award : show line 3 in the form +588 $11.49 $6,756 2,771 D
2022-01-15 Grant or award : show line 4 in the form +653 $9.63 $6,288 3,424 D
2022-03-16 Exercise or conversion : show line 5 in the form +775 4,199 D
2022-03-16 Shares withheld for taxes : show line 6 in the form −269 $10.13 $2,725 3,930 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-16 Exercise or conversion : show line 7 in the form Restricted Share Unit −775 2,323 D
Loading xslF345X03/edgar.xml…